Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dharmasena, D.
Right arrow Articles by Williams, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dharmasena, D.
Right arrow Articles by Williams, J. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1989) 23, 253-259
© 1989 The British Society for Antimicrobial Chemotherapy

research-article

Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD

D. Dharmasena, D. E. Robertsa, G. A. Coles and J. D. Williams

Department of Renal Medicine, University of Wales College of Medicine Cardiff Royal Infirmary aDepartment of Pharmacy, University Hospital of Wales Cardiff, UK

Received 7 July 1988; accepted 25 October 1988

Correspondence: Dr J. D. Williams

The concentration of ciprofloxacin was assayed in plasma and peritoneal dialysate following intraperitoneal administration of the drug in the absence of bacterial peritonitis. After administration of a single dose of 5 mg/kg, ciprofloxacin was rapidly absorbed, producing a peak plasma concentration of 1·9 ± 0·6 mg/l after 3–4 h with an apparent bioavailability of 0·84. In a separate study, following the administration of 25 mg/l for eight consecutive CAPD cycles the intraperitoneal concentration of ciprofloxacin fell to a mean of 8·4±4·6 mg/l after 4 h cycles and to a mean of 3·0±3·2 mg/l after 12 h cycles. During the period of administration the mean plasma concentration was 0·5±0·2 mg/l. Analysis of dialysate for 48 h after cessation of drug administration demonstrated ciprofloxacin to be present in effluent from only two of the six patients, confirming its poor peritoneal elimination.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 pdiHome page
M. P. Fontan, H. D. Cambre, A. Rodriguez-Carmona, A. L. Muniz, and T. G. Falcon
TREATMENT OF PERITONEAL DIALYSIS-RELATED PERITONITIS WITH CIPROFLOXACIN MONOTHERAPY: CLINICAL OUTCOMES AND BACTERIAL SUSCEPTIBILITY OVER TWO DECADES
Perit. Dial. Int., May 1, 2009; 29(3): 310 - 318.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.